The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Novan, Inc(NASDAQ:NOVN) 
Novan, Inc., a clinical development-stage biotechnology company, provides nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical ant...
Website: http://www.novan.com
Founded: 2006
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
Novan Days Payable Outstanding ttm (DPO)
Novan Days Receivable Outstanding ttm (DSO)
Novan Days Inventory Outstanding ttm (DIO)
Novan Op Cashflow Per Share ttm
Novan Free Cashflow Per Share ttm
Novan Cash Per Share ttm
Novan P/S ratio ttm
Novan (GAAP) P/E ratio ttm
Novan P/B ratio ttm
No extra charts and metrics for this ticker.